You are here

Article Text

Article menu
Download PDFPDF
Miscellanea
Archivist
Cystic fibrosis gene therapy: the first trial

https://doi.org/10.1136/archdischild-2015-309332

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In August, Archivist reported on a successful trial of new molecules that enhance function of cystic fibrosis (CF) transmembrane conductance regulator (CFTR) protein at an intracellular level (ADC doi:10.1136/archdischild-2015-309089). Hot on its heels comes a report of the first Phase 2b trial of another completely novel treatment: gene therapy, which involves transferring correct copies of CFTR DNA into lung epithelial cells, by administering it in a complex with cationic liposomes in nebulised form (Alton …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.